# A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer

> **NCT04404543** · PHASE1 · UNKNOWN · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 71 (estimated)

## Conditions studied

- Extensive-Stage Small Cell Lung Cancer

## Interventions

- **DRUG:** SYHA1807
- **DRUG:** SYHA1807

## Key facts

- **NCT ID:** NCT04404543
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 71 (ESTIMATED)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404543, "A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04404543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*